Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,078.22 -1,247.30 (-1.94%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
West Pharmaceutical Services, Inc. (WST)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 26.25B |
| Enterprise value | 25.96B |
| Trailing P/E | 47.55 |
| Forward P/E | 47.17 |
| PEG ratio (5-yr expected) | 6.38 |
| Price/sales (ttm) | 9.22 |
| Price/book (mrq) | 9.79 |
| Enterprise value/revenue | 8.86 |
| Enterprise value/EBITDA | 31.77 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | -1.56% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 415.73 |
| 52-week low 3 | 310.42 |
| 50-day moving average 3 | 376.74 |
| 200-day moving average 3 | 371.23 |
Share statistics
| Avg vol (3-month) 3 | 545.3k |
| Avg vol (10-day) 3 | 492.88k |
| Shares outstanding 5 | 72.84M |
| Implied shares outstanding 6 | 73.21M |
| Float 8 | 72.36M |
| % held by insiders 1 | 0.56% |
| % held by institutions 1 | 95.91% |
| Shares short (15 Apr 2024) 4 | 975.86k |
| Short ratio (15 Apr 2024) 4 | 2.72 |
| Short % of float (15 Apr 2024) 4 | 1.74% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.33% |
| Shares short (prior month 15 Mar 2024) 4 | 1.21M |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 0.22% |
| Trailing annual dividend rate 3 | 0.78 |
| Trailing annual dividend yield 3 | 0.21% |
| 5-year average dividend yield 4 | 0.26 |
| Payout ratio 4 | 10.29% |
| Dividend date 3 | 01 May 2024 |
| Ex-dividend date 4 | 31 Jul 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 19.42% |
| Operating margin (ttm) | 18.06% |
Management effectiveness
| Return on assets (ttm) | 11.40% |
| Return on equity (ttm) | 20.84% |
Income statement
| Revenue (ttm) | 2.93B |
| Revenue per share (ttm) | 39.55 |
| Quarterly revenue growth (yoy) | -3.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 809.6M |
| Net income avi to common (ttm) | 568.7M |
| Diluted EPS (ttm) | 7.57 |
| Quarterly earnings growth (yoy) | -17.60% |
Balance sheet
| Total cash (mrq) | 601.8M |
| Total cash per share (mrq) | 8.26 |
| Total debt (mrq) | 306.6M |
| Total debt/equity (mrq) | 11.44% |
| Current ratio (mrq) | 2.61 |
| Book value per share (mrq) | 36.72 |
Cash flow statement
| Operating cash flow (ttm) | 756.6M |
| Levered free cash flow (ttm) | 143.34M |
© 2024 Yahoo. All rights reserved.